1)Shimomura I, et al:Enhanced expression of PAI-1 in visceral fat;Possible contributor to vascular disease in obesity. Nat Med 2:800-803, 1996
2)Kishida K, et al:Molecular mechanisms of diabetes and atherosclerosis:Role of adiponectin. Endocr Metab Immune Disorder-Drug Targets 12:118-131, 2012
3)Kumada M, et al:Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23:85-89, 2003
4)Ohashi K, et al:Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease. J Am Coll Cardiol 43:1195-1200, 2004
5)Kojima S, et al:Hypercholesterolemia and hypoadiponectinemia are associated with necrotic core-rich coronary plaque. Int J Cardiol 147:371-376, 2011
6)Ryo M, et al:Adiponectin as a biomarker of the metabolic syndrome. Circ J 68:975-981, 2004
7)Nakatsuji H, et al:Binding of adiponectin and C1q in human serum, and clinical significance of the measurement of C1q-adiponectin/total adiponectin ratio. Metabolism 62:109-120, 2013
8)Hirata A, et al:Correlation between serum C1q-adiponectin/total adiponectin ratio and polyvascular lesions detected by vascular ultrasonography in Japanese type 2 diabetics. Metabolism:in press.